Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-25-014033
Filing Date
2025-12-17
Accepted
2025-12-17 07:10:51
Documents
1
Period of Report
2025-12-17

Document Format Files

Seq Description Document Type Size
1 EXDENSUR (DEPEMOKIMAB ULLA) APPROVED BY US FDA a8507l.htm 6-K 58372
  Complete submission text file 0001654954-25-014033.txt   59592
Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom
Business Address 79 NEW OXFORD STREET LONDON United Kingdom 44 20 8047 5000
GSK plc (Filer) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 251577242
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)